Allied Market Research
Loading...
0
New
New
2021
Phospholipid Market

Phospholipid Market by Source (Soy, Eggs, and Others), Form (Powder and Granule), and Application (Nutrition & Supplements, Pharmaceuticals, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A13115
Pages: 295
Aug 2021 | 287 Views
   
Author(s) : Raju Kale , Roshan Deshmukh
Tables: 147
Charts: 71
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Phospholipid Market

Request Now !

The global phospholipid market size was valued at $2,846.1 million in 2020, and is projected to reach $5,647.1 million by 2030, registering a CAGR of 7.1% from 2021 to 2030. In 2020, the soy segment accounted for the highest share in the phospholipid market.   

A phospholipid is a type of lipid molecule, which is made of two fatty acids, a phosphate group, and a glycerol molecule. Phospholipid have several applications such as nutritional, pharmaceutical, and food,. There are many health benefits related to phospholipids, therefore, they are used widely for several studies related to the pharmaceutical industry.  

Phospholipid-Market

Get more information on this report : Request Sample Pages

Phospholipid is a promising natural ingredient for health products, owing to rise in consumer demand for natural supplements and ageing population. Many companies are releasing new natural health products, and some are substituting natural chemicals for synthetic ones in product formulations. Customers are more willing to try complementary and alternative medications, which propels demand for natural products. Customers strongly prefer natural and non-synthetic products to prevent ailments. Naturally sourced ingredients are preferred as customers feel safe. Associated health benefits and inclination of customers toward natural ingredients are the key reasons that drive demand for such products in the market. 

Majority of phospholipids from soy sources are genetically modified. Genetically modified foods are a threat to the environment, pollution of soils, and a long-term threat to human health. It may have unknown long-term consequences that result in immunological alterations in the gut, decreased fertility, and exacerbation, and creation of allergies. It contains high concentrations of plant toxicants that represent thousands of plant biochemicals, many of which may have toxic effects on animals.

Ingredient labeling has become mandatory in developed economies such as the U.S. and the EU countries. This is due to increase in consumer awareness. Food labeling is a medium through which consumers acquire knowledge about the food they buy. Consumers are showing greater interest in natural and green labels. Therefore, phospholipid manufacturers are focused on safety and quality of products that are regulated by several governments to be clinically tested and approved to be used as an ingredient in end use products. 

Strong global concerns about the pandemic, coronavirus, have largely but negatively influenced the global phospholipid market growth in 2020. Moreover, owing the high demand and low supply trends, prices of products increased in 2020 to overcome economic instability. On the contrary, disruptions to supply chain in shipping could lead to temporary shortages in the supply, putting upward pressure on prices in the short term.       

COVID-19 Scenario Analysis:

  • The food and beverages industry has witnessed a high demand in the lockdown period.
  • Most supermarkets and other stores are closed and manufacturers are facing problems such as lack of resources and labor availability, impacting the scale of production.
  • All these factors indirectly harm demand for the phospholipid market.
  • The COVID-19 pandemic has affected the phospholipid market as the lockdown scenario has caused shutdown of many foods and beverages industries, which has led to decline of sales and revenue growth. 
  • The market players are facing loss in exporting products to other countries due to stringent government regulations imposed on export and import. 

According to the phospholipid market analysis, the market is segmented on the basis of source, form, application, and region. Depending on source, the market is divided into soy, eggs and others. By form, it is divided into powder and granule. By application, it is fragmented into nutrition & supplements, pharmaceuticals, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Spain, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Thailand, Singapore, and rest of Asia-Pacific), and LAMEA (Brazil, Argentina, UAE, Nigeria, South Africa, Turkey and rest of LAMEA).    

On the basis of source, the soy segment accounted for the maximum share in the global phospholipid market in 2020, and is expected to remain dominant during the phospholipid market forecast period. Soy is a natural source of phospholipid. Soya phospholipid, particularly commercial lecithin, are widely used as biological active food additives. It has a wide range of biochemical and physical effects.

Phospholipid Market
By Source

Your browser does not support the canvas element.

Other segment would witness the fastest growth, registering a CAGR of 7.6% during the forecast period.

Get more information on this report : Request Sample Pages

On the basis of form, the powder segment accounts for a higher value share. Powdered phospholipid is used in commercial applications of food systems. It is easy to handle and can be easily incorporated as compared to other forms. Moreover, it has an advantage of neutral color and flavor. It is an essentially ready nutraceutical that offers nutritional benefits to consumers. Furthermore, it has its role in dietary foods such as capsules & tablets, bakery products, anti-sticking of confections, and convenience foods such as sauces and soups.  

Phospholipid Market
By Form

Your browser does not support the canvas element.

Granule Segment witnssed a major growth rate of 8.0%

Get more information on this report : Request Sample Pages

On the basis of application, the nutrition & supplements segment held a significant phospholipid market share in 2020. Vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other nutritional supplements are all products that are used to augment nutritional content of food. These supplements can also be used to treat excessive cholesterol, digestive problems, and clogged milk ducts while breast-feeding. 

Phospholipid Market
By Application

Your browser does not support the canvas element.

Nutrition & Supplement Segment held the major share of 43.8% in 2020

Get more information on this report : Request Sample Pages

On the basis of region, North America dominated the phospholipid market in 2020, and accounted for maximum market share. North America currently is one of the leading markets of the phospholipid industry, owing to extreme demand for phospholipid products in nutrition & supplements industry.  

Phospholipid Market
By Region

2030
Asia-pacific 
North America
Europe
Lamea

Asia-Pacific held the major share of 38.2% in 2020

Get more information on this report : Request Sample Pages

Players in the phospholipid market have adopted business expansion and product launch as their key developmental strategies to expand their market share, increase profitability, and remain competitive in the market. The key players profiled in the report include Archer Daniels Midland Company, Bunge Ltd, Cargill, Incorporated, DuPont de Nemours, Inc, Kewpie Corporation, Lasenor Emul SL, Lipoid GmbH, SojaProtein a.d, VAV Life Sciences Pvt. Ltd, and Wilmar International Ltd. 

Key benefits for stakeholders   

  • The report provides quantitative analysis of the current Phospholipid market trends, estimations, and dynamics of the market size from 2020 to 2030 to identify the prevailing Phospholipid market opportunities. 
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network. 
  • In-depth analysis and the market size & segmentation assist to determine the market potential.
  • The major countries in each region are mapped according to their revenue contribution to the market.     
  • The market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of the market players in the Phospholipid industry. 

Key market segments 

By Source

  • Soy
  • Eggs
  • Others

By Form

  • Powder
  • Granule

By Application

  • Nutrition & supplements
  • Pharmaceuticals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany 
    • France
    • UK
    • Italy
    • Spain 
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • Thailand
    • Singapore
    • Rest of Asia-Pacific 
  • LAMEA 
    • Brazil
    • Argentina
    • UAE
    • Nigeria
    • South Africa
    • Turkey
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION
1.1.Key benefits for stakeholders
1.2.Key market segments
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top impacting factors
3.2.2.Top investment pockets
3.3.Value chain analysis
3.4.Porter’s five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Growing Demand for Naturally Sourced Ingredients
3.5.1.2.Increasing Demand for Phospholipid in the Pharmaceutical and Cosmetics Industries
3.5.2.Restraints
3.5.2.1.Genetically modified foods may act as a threat to the environment
3.5.3.Opportunities
3.5.3.1.Growing Demand for Alternate Sources of Phospholipid
3.5.3.2.Increase in demand for label-friendly products among consumers
3.6.Market share analysis
3.6.1.By source
3.6.2.By form
3.6.3.By application
3.6.4.By region
3.7.Parent/Peer Analysis
3.8.Impact of COVID-19 on the phospholipid market
CHAPTER 4:PHOSPHOLIPID MARKET, BY SOURCE
4.1.Overview
4.1.1.Market size and forecast
4.2.Soy
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Egg
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:PHOSPHOLIPID MARKET, FORM
5.1.Overview
5.1.1.Market size and forecast
5.2.Powder
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.4.Granule
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
CHAPTER 6:PHOSPHOLIPID MARKET, APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Nutrition & supplements
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Pharmaceuticals
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.Others
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
CHAPTER 7:PHOSPHOLIPID MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast, by region
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by source
7.2.3.Market size and forecast, by form
7.2.4.Market size and forecast, by application
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.Market size and forecast, by source
7.2.5.1.2.Market size and forecast, by form
7.2.5.1.3.Market size and forecast, by application
7.2.5.2.Canada
7.2.5.2.1.Market size and forecast, by source
7.2.5.2.2.Market size and forecast, by form
7.2.5.2.3.Market size and forecast, by application
7.2.5.3.Mexico
7.2.5.3.1.Market size and forecast, by source
7.2.5.3.2.Market size and forecast, by form
7.2.5.3.3.Market size and forecast, by application
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by source
7.3.3.Market size and forecast, by form
7.3.4.Market size and forecast, by application
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Market size and forecast, by source
7.3.5.1.2.Market size and forecast, by form
7.3.5.1.3.Market size and forecast, by application
7.3.5.2.France
7.3.5.2.1.Market size and forecast, by source
7.3.5.2.2.Market size and forecast, by form
7.3.5.2.3.Market size and forecast, by application
7.3.5.3.UK
7.3.5.3.1.Market size and forecast, by source
7.3.5.3.2.Market size and forecast, by form
7.3.5.3.3.Market size and forecast, by application
7.3.5.4.Italy
7.3.5.4.1.Market size and forecast, by source
7.3.5.4.2.Market size and forecast, by form
7.3.5.4.3.Market size and forecast, by application
7.3.5.5.Spain
7.3.5.5.1.Market size and forecast, by source
7.3.5.5.2.Market size and forecast, by form
7.3.5.5.3.Market size and forecast, by application
7.3.5.6.Russia
7.3.5.6.1.Market size and forecast, by source
7.3.5.6.2.Market size and forecast, by form
7.3.5.6.3.Market size and forecast, by application
7.3.5.7.Rest of Europe
7.3.5.7.1.Market size and forecast, by source
7.3.5.7.2.Market size and forecast, by form
7.3.5.7.3.Market size and forecast, by application
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by source
7.4.3.Market size and forecast, by form
7.4.4.Market size and forecast, by application
7.4.5.Market size and forecast, by country
7.4.5.1.China
7.4.5.1.1.Market size and forecast, by source
7.4.5.1.2.Market size and forecast, by form
7.4.5.1.3.Market size and forecast, by application
7.4.5.2.Japan
7.4.5.2.1.Market size and forecast, by source
7.4.5.2.2.Market size and forecast, by form
7.4.5.2.3.Market size and forecast, by application
7.4.5.3.India
7.4.5.3.1.Market size and forecast, by source
7.4.5.3.2.Market size and forecast, by form
7.4.5.3.3.Market size and forecast, by application
7.4.5.4.Australia
7.4.5.4.1.Market size and forecast, by source
7.4.5.4.2.Market size and forecast, by form
7.4.5.4.3.Market size and forecast, by application
7.4.5.5.South Korea
7.4.5.5.1.Market size and forecast, by source
7.4.5.5.2.Market size and forecast, by form
7.4.5.5.3.Market size and forecast, by application
7.4.5.6.Thailand
7.4.5.6.1.Market size and forecast, by source
7.4.5.6.2.Market size and forecast, by form
7.4.5.6.3.Market size and forecast, by application
7.4.5.7.Singapore
7.4.5.7.1.Market size and forecast, by source
7.4.5.7.2.Market size and forecast, by form
7.4.5.7.3.Market size and forecast, by application
7.4.5.8.Rest of Asia-Pacific
7.4.5.8.1.Market size and forecast, by source
7.4.5.8.2.Market size and forecast, by form
7.4.5.8.3.Market size and forecast, by application
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by source
7.5.3.Market size and forecast, by form
7.5.4.Market size and forecast, by application
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Market size and forecast, by source
7.5.5.1.2.Market size and forecast, by form
7.5.5.1.3.Market size and forecast, by application
7.5.5.2.Argentina
7.5.5.2.1.Market size and forecast, by source
7.5.5.2.2.Market size and forecast, by form
7.5.5.2.3.Market size and forecast, by application
7.5.5.3.UAE
7.5.5.3.1.Market size and forecast, by source
7.5.5.3.2.Market size and forecast, by form
7.5.5.3.3.Market size and forecast, by application
7.5.5.4.Nigeria
7.5.5.4.1.Market size and forecast, by source
7.5.5.4.2.Market size and forecast, by form
7.5.5.4.3.Market size and forecast, by application
7.5.5.5.South Africa
7.5.5.5.1.Market size and forecast, by source
7.5.5.5.2.Market size and forecast, by form
7.5.5.5.3.Market size and forecast, by application
7.5.5.6.Turkey
7.5.5.6.1.Market size and forecast, by source
7.5.5.6.2.Market size and forecast, by form
7.5.5.6.3.Market size and forecast, by application
7.5.5.7.Rest of LAMEA
7.5.5.7.1.Market size and forecast, by source
7.5.5.7.2.Market size and forecast, by form
7.5.5.7.3.Market size and forecast, by application
CHAPTER 8:COMPETITION LANDSCAPE
8.1.Top winning strategies
8.2.Product mapping
8.3.Competitive dashboard
8.4.Competitive heat map
8.5.Key developments
8.5.1.Acquisition
8.5.2.Business Expansion
8.5.3.Product Launch
CHAPTER 9:COMPANY PROFILES
9.1.ARCHER-DANIELS-MIDLAND COMPANY
9.1.1.Company overview
9.1.2.Key Executives
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.Business performance
9.1.7.Key strategic moves and developments
9.2.Bunge Ltd.
9.2.1.Company overview
9.2.2.Key Executives
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.Business performance
9.2.7.Key strategic moves and developments
9.3.Cargill, Incorporated
9.3.1.Company overview
9.3.2.Key Executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Business performance
9.4.DuPont de Nemours, Inc.
9.4.1.Company overview
9.4.2.Key executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.R&D expenditure
9.4.7.Business performance
9.4.8.Key strategic moves and developments
9.5.Kewpie Corporation
9.5.1.Company overview
9.5.2.Key Executives
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio
9.5.6.R&D Expenditure
9.5.7.Business performance
9.6.Lasenor Emul SL
9.6.1.Company overview
9.6.2.Key Executives
9.6.3.Company snapshot
9.6.4.Product portfolio
9.6.5.Key strategic moves and developments
9.7.Lipoid GmbH
9.7.1.Company overview
9.7.2.Key Executives
9.7.3.Company snapshot
9.7.4.Product portfolio
9.8.SojaProtein a.d
9.8.1.Company overview
9.8.2.Key Executives
9.8.3.Company snapshot
9.8.4.Product portfolio
9.9.VAV Life Sciences Pvt. Ltd.
9.9.1.Company overview
9.9.2.Key Executives
9.9.3.Company snapshot
9.9.4.Product portfolio
9.9.5.Key strategic moves and developments
9.10.Wilmar International Ltd.
9.10.1.Company overview
9.10.2.Key Executives
9.10.3.Company snapshot
9.10.4.Operating business segments
9.10.5.Product portfolio
9.10.6.Business performance

LIST OF TABLES
TABLE 01.PHOSPHOLIPID MARKET REVENUE, BY SOURCE, 2020–2030 ($MILLION)
TABLE 02.SOY PHOSPHOLIPID MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 03.EGG PHOSPHOLIPID MARKET REVENUE, BY REGION 2020–2030 ($MILLION)
TABLE 04.OTHER PHOSPHOLIPID MARKET REVENUE, BY REGION 2020–2030 ($MILLION)
TABLE 05.PHOSPHOLIPID MARKET REVENUE, BY FORM, 2020–2030($MILLION)
TABLE 06.PHOSPHOLIPID MARKET REVENUE FOR POWDER, BY REGION, 2020–2030 ($MILLION)
TABLE 07.PHOSPHOLIPID MARKET REVENUE FOR GRANULE, BY REGION, 2020–2030 ($MILLION)
TABLE 08.PHOSPHOLIPID MARKET REVENUE, BY APPLICATION, 2020–2030($MILLION)
TABLE 09.PHOSPHOLIPID MARKET REVENUE FOR NUTRITION & SUPPLEMENTS, BY REGION, 2020–2030 ($MILLION)
TABLE 10.PHOSPHOLIPID MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.PHOSPHOLIPID MARKET REVENUE FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 12.PHOSPHOLIPID MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 13.NORTH AMERICA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 14.NORTH AMERICA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 15.NORTH AMERICA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 16.NORTH AMERICA PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 17.U.S. PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 18.U.S. PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 19.U.S. PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 20.CANADA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 21.CANADA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 22.CANADA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.MEXICO PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 24.MEXICO PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 25.MEXICO PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 26.EUROPE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 27.EUROPE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 28.EUROPE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 29.EUROPE PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 30.GERMANY PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 31.GERMANY PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 32.GERMANY PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33.FRANCE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 34.FRANCE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 35.FRANCE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 36.UK PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 37.UK PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 38.UK PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 39.ITALY PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 40.ITALY PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 41.ITALY PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 42.SPAIN PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 43.SPAIN PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 44.SPAIN PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 45.RUSSIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 46.RUSSIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 47.RUSSIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 48.REST OF EUROPE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 49.REST OF EUROPE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 50.REST OF EUROPE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 52.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 53.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 54.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55.CHINA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 56.CHINA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 57.CHINA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 58.JAPAN PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 59.JAPAN PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 60.JAPAN PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 61.INDIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 62.INDIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 63.INDIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 64.AUSTRALIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 65.AUSTRALIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 66.AUSTRALIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67.SOUTH KOREA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 68.SOUTH KOREA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 69.SOUTH KOREA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 70.THAILAND PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 71.THAILAND PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 72.THAILAND PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 73.SINGAPORE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 74.SINGAPORE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 75.SINGAPORE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 78.REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 79.LAMEA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 80.LAMEA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 81.LAMEA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 82.LAMEA PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 83.BRAZIL PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 84.BRAZIL PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 85.BRAZIL PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 86.ARGENTINA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 87.ARGENTINA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 88.ARGENTINA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 89.UAE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 90.UAE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 91.UAE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 92.NIGERIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 93.NIGERIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 94.NIGERIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 95.SOUTH AFRICA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 96.SOUTH AFRICA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 97.SOUTH AFRICA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 98.TURKEY PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 99.TURKEY PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 100.TURKEY PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 101.REST OF LAMEA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)
TABLE 102.REST OF LAMEA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 103.REST OF LAMEA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 104.ARCHER-DANIELS-MIDLAND COMPANY: KEY EXECUTIVES
TABLE 105.ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 106.ARCHER-DANIELS-MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 107.ARCHER-DANIELS-MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 108.ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2017–2019 ($MILLION)
TABLE 109.BUNGE LTD.: KEY EXECUTIVES
TABLE 110.BUNGE LTD.: COMPANY SNAPSHOT
TABLE 111.BUNGE LTD.: OPERATING SEGMENTS
TABLE 112.BUNGE LTD.: PRODUCT PORTFOLIO
TABLE 113.BUNGE LTD.: NET SALES, 2018–2020 ($MILLION)
TABLE 114.CARGILL, INCORPORATED: KEY EXECUTIVES
TABLE 115.CARGILL, INCORPORATED: COMPANY SNAPSHOT
TABLE 116.CARGILL, INCORPORATED: OPERATING SEGMENTS
TABLE 117.CARGILL, INCORPORATED: PRODUCT PORTFOLIO
TABLE 118.CARGILL, INCORPORATED: NET SALES, 2018–2020 ($MILLION)
TABLE 119.DUPONT DE NEMOURS, INC.: KEY EXECUTIVES
TABLE 120.DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT
TABLE 121.DUPONT DE NEMOURS, INC.: OPERATING SEGMENTS
TABLE 122.DUPONT DE NEMOURS, INC.: PRODUCT PORTFOLIO
TABLE 123.DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 124.DUPONT DE NEMOURS, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 125.KEWPIE CORPORATION: KEY EXECUTIVES
TABLE 126.KEWPIE CORPORATION: COMPANY SNAPSHOT
TABLE 127.KEWPIE CORPORATION: OPERATING SEGMENTS
TABLE 128.KEWPIE CORPORATION: PRODUCT PORTFOLIO
TABLE 129.KEWPIE CORPORATION: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 130.KEWPIE CORPORATION: NET SALES, 2018–2020 ($MILLION)
TABLE 131.LASENOR EMUL SL: KEY EXECUTIVES
TABLE 132.LASENOR EMUL SL: COMPANY SNAPSHOT
TABLE 133.LASENOR EMUL SL: PRODUCT PORTFOLIO
TABLE 134.LIPOID GMBH: KEY EXECUTIVES
TABLE 135.LIPOID GMBH: COMPANY SNAPSHOT
TABLE 136.LIPOID GMBH: PRODUCT PORTFOLIO
TABLE 137.SOJAPROTEIN A.D: KEY EXECUTIVES
TABLE 138.SOJAPROTEIN A.D: COMPANY SNAPSHOT
TABLE 139.SOJAPROTEIN A.D: PRODUCT PORTFOLIO
TABLE 140.VAV LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 141.VAV LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 142.VAV LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 143.WILMAR INTERNATIONAL LTD.: KEY EXECUTIVES
TABLE 144.WILMAR INTERNATIONAL LTD.: COMPANY SNAPSHOT
TABLE 145.WILMAR INTERNATIONAL LTD.: OPERATING SEGMENTS
TABLE 146.WILMAR INTERNATIONAL LTD.: PRODUCT PORTFOLIO
TABLE 147.WILMAR INTERNATIONAL LTD.: NET SALES, 2018–2020 ($MILLION)

LIST OF FIGURES
FIGURE 01.GLOBAL PHOSPHOLIPID MARKET SNAPSHOT
FIGURE 02.GLOBAL PHOSPHOLIPID MARKET: SEGMENTATION
FIGURE 03.TOP IMPACTING FACTORS
FIGURE 04.TOP INVESTMENT POCKETS
FIGURE 05.TOP PLAYERS POSITIONING
FIGURE 06.VALUE CHAIN ANALYSIS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE BARGAINING POWER OF BUYERS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 12.PHOSPHOLIPID MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.PARENT/PEER ANALYSIS
FIGURE 14.PHOSPHOLIPID MARKET REVENUE, BY SOURCE, 2020 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SOY PHOSPHOLIPID MARKET REVENUE, BY COUNTRY, 2020 & 2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS FOR EGG PHOSPHOLIPID MARKET REVENUE, BY COUNTRY, 2020 & 2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS FOR OTHER PHOSPHOLIPID MARKET REVENUE, BY COUNTRY, 2020 & 2030(%)
FIGURE 18.PHOSPHOLIPID MARKET, BY FORM, 2020 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR POWDER, BY COUNTRY, 2020 & 2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR GRANULE, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21.PHOSPHOLIPID MARKET, BY APPLICATION, 2020 (%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR NUTRITION & SUPPLEMENTS, BY COUNTRY, 2020 & 2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PHOSPHOLIPID MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 25.PHOSPHOLIPID MARKET, BY REGION, 2020 (%)
FIGURE 26.U.S. PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 27.CANADA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 28.MEXICO PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 29.GERMANY PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 30.FRANCE PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 31.UK PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 32.ITALY PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 33.SPAIN PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 34.RUSSIA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 35.REST OF EUROPE PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 36.CHINA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 37.JAPAN PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 38.INDIA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 39.AUSTRALIA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 40.SOUTH KOREA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 41.THAILAND PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 42.SINGAPORE PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 43.REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 44.BRAZIL PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 45.ARGENTINA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 46.UAE PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 47.NIGERIA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 48.SOUTH AFRICA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 49.TURKEY PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 50.REST OF LAMEA PHOSPHOLIPID MARKET, 2020–2030 ($MILLION)
FIGURE 51.TOP WINNING STRATEGIES, BY YEAR, 2017–2019
FIGURE 52.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2019 (%)
FIGURE 53.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 54.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 55.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 56.ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2017–2019 ($MILLION)
FIGURE 57.ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 58.ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.BUNGE LTD.: NET SALES, 2018–2020 ($MILLION)
FIGURE 60.BUNGE LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 61.CARGILL, INCORPORATED: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 63.DUPONT DE NEMOURS, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 64.DUPONT DE NEMOURS, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.DUPONT DE NEMOURS, INC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 66.KEWPIE CORPORATION: R&D EXPENDITURE, 2018–2020 ($MILLION)
FIGURE 67.KEWPIE CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 68.KEWPIE CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 69.WILMAR INTERNATIONAL LTD.: NET SALES, 2018–2020 ($MILLION)
FIGURE 70.WILMAR INTERNATIONAL LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 71.WILMAR INTERNATIONAL LTD.: REVENUE SHARE BY REGION, 2020 (%)

 
 

According to the CXO of the leading companies, the factors such as rise in demand for green and organic food and growth in trends among consumers regarding health benefits such as weight loss and calorie concern drive the demand for phospholipid. However, threat to the environment by genetically modified food and adverse reaction of phospholipid on human health are expected to hamper the market growth during the forecast period. Conversely, increase in demand for label-friendly products in consumers and R&D activities in the field of phospholipid market is expected to provide substantial growth opportunity for the industry players in the near future.  

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The global phospholipid market was valued at $2,846.1 million in 2020, and is projected to reach $5,647.1 million by 2030, registering a CAGR of 7.1% from 2021 to 2030.

A. The CAGR of the Phospholipid Market is 7.1%.

A. Kindly get in touch with the sales team for better options.

A. Source, form, and Application are the segments of Phospholipid Market.

A. 2020 is the base year calculated in the Phospholipid market report.

A. The top companies in the Phospholipid Market are Archer Daniels Midland Company, Bunge Ltd, Cargill, Incorporated, DuPont de Nemours, Inc, Kewpie Corporation, Lasenor Emul SL, Lipoid GmbH, SojaProtein a.d, VAV Life Sciences Pvt. Ltd, and Wilmar International Ltd.

A. North America dominated the phospholipid market in 2020, and accounted for maximum market share.

A. Asia-Pacific region witness a major growth rate and will provide more business opportunities for Phospholipid Market in future.

A. Slightly declined observed in the covid-19 in 2020 in Phospholipid Market.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Phospholipid Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers